Journal of Pharmaceutical Health Services Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Medicines policy issues for Saudi Arabia: priorities and model
This article describes the need to build a conceptual model and the future directions for medicines policy in the country. The model is needed to narrate and document the set of challenges with regard to workforce, professional d evelopment, human and health services for the pharmaceutical and medicines sector. A conceptual model could aid to build and identify priority medicines policy issues. The model describes stakeholder involvement, including government, policymakers, industry, academics and consumers who could be invo lved in the policy development. Interaction between these stakeholders, as well as thematic documen...
Source: Journal of Pharmaceutical Health Services Research - August 6, 2019 Category: Drugs & Pharmacology Authors: Ahmer Hameed Mirza, Syed Shahzad Hasan, Faris El ‐Dahiyat, Zaheer‐Ud‐Din Babar Tags: Short Communication Source Type: research

Policies influencing access to new targeted oncologic drugs in Ecuadorian hospitals: an interrupted time series analysis
ConclusionsTransferring to DTCs the responsibility to select new drugs produced an increase in prescription intensity of targeted oncologic drugs, mainly in the private sector. The second intervention changed this trend. Combination of different levels of decision, meaning a DTC analysis plus a reanalysis by a central body, seems to limit new prescriptions of targeted oncologic drugs. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - August 6, 2019 Category: Drugs & Pharmacology Authors: Carlos E. Dur án, Monique Elseviers, Robert Vander Stichele, Sylvie Rottey, Patricia Granja, Thierry Christiaens Tags: Research Paper Source Type: research

Evaluation and comparison of the utilization of anti ‐epileptic drugs in Indian paediatric patients with global usage data
ConclusionsOlder generation AEDs are still used in majority of patients as mono and dual therapy. Among the newer generation AEDs, there is an increase in the utilization of levetiracetam. Prescription of AEDs in our study goes in line with Asian countries but differs with the European counterparts due to various reasons. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - July 28, 2019 Category: Drugs & Pharmacology Authors: Bijoy Kumar Panda, Ruth Susan George, Neha Vijay Parekh, Adhiraj Dharmadhikari, Sandeep Patil Tags: Research Paper Source Type: research

Barriers to adverse drug reaction reporting in community practice in the UAE
ConclusionsPlace of graduation, the complexity of the reporting process and lack of reporting skills were identified as the main barriers hindering ADR reporting. To overcome these difficulties and enhance the reporting level, training programmes on P.V. system, spontaneous reporting and professional guidance of pharmacists should be implemented. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - July 24, 2019 Category: Drugs & Pharmacology Authors: Munther S. Alnajjar, Lama M. Zamzoum, Dima A. Saeed Tags: Research Paper Source Type: research

Clopidogrel safety communication impact on histamine ‐2 receptor antagonist and proton‐pump inhibitor use trends
ConclusionsOverall H2RA and PPI use did not change among adults taking clopidogrel from 2007 through 2014. Prescribers must consider acid reducing agents that will not interact with clopidogrel. Future studies should evaluate the use of PPIs and H2RAs with dual antiplatelet therapy and in patients with a high risk of gastrointestinal bleeding. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - July 18, 2019 Category: Drugs & Pharmacology Authors: Amie Armbrister, Annette Vidal, Shanique James, Claudia Nunez Chiang, Jennifer G. Steinberg, Alexandra Perez Tags: Research Paper Source Type: research

Medication adherence in patients with psychiatric disorders in Tehran
ConclusionNon ‐adherence to treatment is a major problem in patients, and the intervention of pharmacists as the most accessible of medical staff as well as physicians can help to persuade patients to adhere and continually take medicines. Some issues such as the side effects of medications, patients' lack of b elief in the need for treatment and patients' uncertainty about the effectiveness of medicines were the most important factors contributing to their non‐adherent behaviour. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - July 9, 2019 Category: Drugs & Pharmacology Authors: Gholamhossein Mehralian, Zahra Sharif, Ghazal Abbasian Tags: Research Paper Source Type: research

Views regarding the safety and efficacy of medicines used in children: comparing originators and local generics in Jordan
ConclusionsThe majority of respondents thought that medicines used in children were effective and safe. It was thought that local generics used in children were as effective as originator medicines. However, almost one ‐third of respondents thought that local generics were not as safe as originator medicines. Respondents reported high levels of confidence in the pharmacist as an important part of the healthcare team when treating children. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - June 16, 2019 Category: Drugs & Pharmacology Authors: Tareq L. Mukattash, Nizar M. Mhaidat, Ali Al-Khawaldeh, Anan S. Jarab, Mohammad B. Nusair Tags: Research Paper Source Type: research

Pharmaceutical pricing policies in Qatar and Lebanon: narrative review and document analysis
ConclusionsThe pharmaceutical pricing policies implemented in Qatar and Lebanon are reflective of both the advancements in the human capital and financial resources of the nations and are in line with the World Health Organization ‐recommended pricing policies for developing countries. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - June 2, 2019 Category: Drugs & Pharmacology Authors: Nada Abdel Rida, Mohamed Izham Mohamed Ibrahim, Zaheer ‐Ud‐Din Babar Tags: Review Source Type: research

Orphan drug policies in different countries
ConclusionsComparison of different legislations and policies in each country can be used to identify and address deficiencies in the field of RDs and improve accessibility of ODs. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - May 26, 2019 Category: Drugs & Pharmacology Authors: Amar Abbas, Janis Vella Szijj, Lilian M. Azzopardi, Anthony Serracino Inglott Tags: Research Paper Source Type: research

Issue Information
Journal of Pharmaceutical Health Services Research, Volume 10, Issue 2, Page 157-158, June 2019. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - May 15, 2019 Category: Drugs & Pharmacology Tags: Issue Information Source Type: research

Deprescribing: an emerging role for pharmacists
Journal of Pharmaceutical Health Services Research, Volume 10, Issue 2, Page 159-160, June 2019. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - May 15, 2019 Category: Drugs & Pharmacology Authors: Barry A. Bleidt Tags: Editorial Source Type: research

The innovation paradox: pharmaceutical marketing exclusivity and incentives for drug development
ConclusionsIf the length of the pre ‐market process correlates with particular drug types, disease targets, or studied outcomes, we may be offering an inadequate incentive in entire areas of medicine where we have a critical need for new treatments. (Source: Journal of Pharmaceutical Health Services Research)
Source: Journal of Pharmaceutical Health Services Research - May 15, 2019 Category: Drugs & Pharmacology Authors: Erika Lietzan, Kristina M. L. Acri n ée Lybecker Tags: Research Paper Source Type: research